These 4 Measures Indicate That Dishman Carbogen Amcis (NSE:DCAL) Is Using Debt In A Risky Way
Jan 16
Have your own idea? Try our Stock Screener
Indian (NIFTY) Life Sciences Industry Analysis
UpdatedJan 20, 2025
DataAggregated Company Financials
Companies18
- 7D1.1%
- 3M-1.1%
- 1Y51.5%
- YTD-3.0%
In the last week, the Life Sciences industry is up 1.1%, with Divi's Laboratories up 2.5%. This takes the industry's 12 month performance to a gain of 51%. Earnings are forecast to grow by 23% annually.
Industry Valuation and Performance
Has the Indian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 20 Jan 2025 | ₹2.5t | ₹269.1b | ₹30.1b | 50.9x | 83.6x | 9.3x |
| Wed, 18 Dec 2024 | ₹2.5t | ₹269.1b | ₹30.1b | 52.8x | 82.1x | 9.2x |
| Fri, 15 Nov 2024 | ₹2.3t | ₹254.0b | ₹28.9b | 47.8x | 80.5x | 9.2x |
| Sun, 13 Oct 2024 | ₹2.5t | ₹247.6b | ₹26.3b | 50.7x | 93.7x | 9.9x |
| Tue, 10 Sep 2024 | ₹2.2t | ₹247.6b | ₹26.3b | 50.3x | 84.4x | 9x |
| Thu, 08 Aug 2024 | ₹2.0t | ₹205.8b | ₹24.7b | 38.1x | 79.3x | 9.5x |
| Sat, 06 Jul 2024 | ₹1.8t | ₹202.0b | ₹23.9b | 37x | 75.5x | 8.9x |
| Mon, 03 Jun 2024 | ₹1.7t | ₹195.1b | ₹21.6b | 31.8x | 76.4x | 8.5x |
| Wed, 01 May 2024 | ₹1.5t | ₹167.8b | ₹18.7b | 30.7x | 79.1x | 8.8x |
| Fri, 29 Mar 2024 | ₹1.3t | ₹168.5b | ₹18.6b | 27.4x | 71.2x | 7.9x |
| Sun, 25 Feb 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 31.5x | 75.9x | 8.4x |
| Tue, 23 Jan 2024 | ₹1.4t | ₹165.9b | ₹18.9b | 31.5x | 73.3x | 8.3x |
| Thu, 21 Dec 2023 | ₹1.3t | ₹155.9b | ₹18.1b | 21x | 73.4x | 8.5x |
| Sat, 18 Nov 2023 | ₹1.3t | ₹156.5b | ₹18.1b | 22.1x | 74.3x | 8.6x |
| Mon, 16 Oct 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 25.7x | 70.9x | 9x |
| Wed, 13 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 25.4x | 72.6x | 9.2x |
| Fri, 11 Aug 2023 | ₹1.4t | ₹160.2b | ₹23.3b | 30.6x | 60.7x | 8.8x |
| Sun, 09 Jul 2023 | ₹1.4t | ₹156.5b | ₹23.0b | 28.7x | 59.2x | 8.7x |
| Tue, 06 Jun 2023 | ₹1.3t | ₹157.3b | ₹23.0b | 28.6x | 55.9x | 8.2x |
| Thu, 04 May 2023 | ₹1.2t | ₹162.6b | ₹28.7b | 33.4x | 42.5x | 7.5x |
| Sat, 01 Apr 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 31.3x | 37.3x | 6.6x |
| Mon, 27 Feb 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 32.3x | 38x | 6.8x |
| Wed, 25 Jan 2023 | ₹1.2t | ₹166.4b | ₹34.6b | 29.8x | 34.9x | 7.3x |
| Fri, 23 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 31x | 35.9x | 7.5x |
| Sun, 20 Nov 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 29.2x | 34.8x | 7.3x |
| Tue, 18 Oct 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 36.3x | 35.1x | 7.7x |
| Thu, 15 Sep 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 37.5x | 36.2x | 8x |
| Sat, 13 Aug 2022 | ₹1.3t | ₹159.6b | ₹34.3b | 36.9x | 38.2x | 8.2x |
| Mon, 11 Jul 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 32.9x | 37.9x | 8.2x |
| Wed, 08 Jun 2022 | ₹1.2t | ₹158.3b | ₹34.2b | 31.4x | 35.8x | 7.7x |
| Fri, 06 May 2022 | ₹1.5t | ₹149.3b | ₹29.2b | 35.1x | 51.1x | 10x |
| Sun, 03 Apr 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 35.1x | 51.5x | 10.2x |
| Tue, 01 Mar 2022 | ₹1.4t | ₹148.3b | ₹29.4b | 33.2x | 49.2x | 9.7x |
| Thu, 27 Jan 2022 | ₹1.4t | ₹138.5b | ₹24.7b | 40x | 57.4x | 10.2x |
Price to Earnings Ratio
57.4x
Current Industry PE
- Investors are optimistic on the Indian Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 83.6x which is higher than its 3-year average PE of 59.9x.
- The industry is trading close to its 3-year average PS ratio of 8.5x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have grown 6.8% per year over the last three years.
- Revenues for these companies have grown 25% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | -0.26% | |
| Healthcare | -1.99% | |
| Life Sciences | 1.08% | |
| Clinical Research and Equipment | 1.08% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIVISLAB Divi's Laboratories | ₹6.00k | 4.7% +₹71.2b | 64.4% | PE86.8x | |
| INDGN Indegene | ₹673.75 | 11.7% +₹16.8b | n/a | PE43.2x | |
| SAILIFE Sai Life Sciences | ₹727.70 | 2.5% +₹3.7b | n/a | PE122.3x | |
| AKUMS Akums Drugs and Pharmaceuticals | ₹626.50 | 2.8% +₹2.7b | n/a | PE35.5x | |
| WINDLAS Windlas Biotech | ₹1.01k | 8.8% +₹1.7b | 112.4% | PE34.6x |
